Related by context. All words. (Click for frequent words.) 72 ABCSG 68 Multicenter Study 64 HIV Cohort Study 62 Post VSE POST 60 Postmenopausal Hormone Therapy 60 Prospective Randomized 59 Gastric Cancer 59 NCIC Clinical Trials 58 Randomized Study 58 Kantonsspital 58 Multicenter Phase 57 Deutsches Herzzentrum 57 Multicenter 57 Oncologic 56 Randomized Phase II 56 Oral Fingolimod 56 multicenter randomized Phase III 56 Plaut Aktiengesellschaft 56 Multicentre 56 Multicenter Randomized 56 Bowel Project NSABP 56 Rigshospitalet Copenhagen Denmark 55 Chronic Heart Failure 55 dose escalation clinical 55 Hematological 55 Proc Am Soc 55 Stent Thrombosis 55 daily WirtschaftsBlatt 55 Preclinical Study 55 Aneurysm Repair 54 Announcement acc 54 NSABP B 54 LHRH receptor positive 54 number NCT# ClinicalTrials.gov 54 Arabian Ready Mix 54 Gynecologic Oncology Group 54 Atypical Hemolytic Uremic Syndrome 54 Hemodialysis Patients 54 Gastrointestinal Oncology 54 pianist Florian Birsak 54 By JENNIFER LEARN 54 multicentre randomized 54 Renal Cancer 54 Hepatocellular Carcinoma 54 Bawag PSK 54 Phase III Clinical Trial 54 Myocardial Infarction TIMI Study 54 Clinical Outcome 53 Autologous Stem Cell Transplantation 53 Study Evaluating 53 Cord Blood Stem Cells 53 Advanced Renal Cell 53 Soft Tissue Sarcoma 53 Controlled Trial 53 CALGB 53 swimmer Markus Rogan 53 Antiviral Therapy 53 DJ EANS 53 H. Erich Wichmann 53 Neoadjuvant 53 Bosutinib 53 Marrow Transplant 53 multicenter phase 53 Intensive Care Medicine 53 prospective multicentre 53 Polymorphisms 53 multicenter placebo controlled 53 #nd EORTC NCI 53 Otto von Guericke 53 Phase Ib II 53 Prospective Multicenter 53 Gunther Weidlinger 52 Screening Trial 52 Intervention Trial 52 Radiation Therapy Oncology 52 Pediatric Endocrinology 52 Pooled Analysis 52 EORTC 52 Thoracic Oncology 52 Histopathological 52 Infection Biology 52 Acute Liver Failure 52 Prolongs Survival 52 News Unternehmensnachrichten DGAP Adhoc 52 Eluting Stent 52 BCIRG 52 Prostate Lung Colorectal 52 surgically resected 52 Receives Marketing Authorization 52 multicentric 52 Dialysis Outcomes 52 papillary renal cell carcinoma 52 multicenter prospective 52 Val HeFT 52 Lymphocytic 52 CALERIE 52 Pivotal Trial 52 AIDS Clinical Trials 52 Angiology 52 Randomised Controlled Trial 51 multicenter randomized controlled 51 prospective observational 51 Antitumor 51 randomized Phase III 51 citizen Adriana Iliescu 51 Basilea Toctino R 51 J Clin Oncol 51 NCCTG N# 51 Biological Effects 51 de Recherche Clinique 51 XIENCE V Stent System 51 Functional Neurosurgery 51 undergoing androgen deprivation 51 Allogeneic 51 prostate carcinoma 51 TG MV 51 Complicated Skin 51 Anticancer Drug 51 Multicenter Trial 51 Adjuvant Breast Cancer 51 recurrent malignant glioma 51 Renal Artery 51 Chronic Lymphocytic Leukemia 51 Coronary Angiography 51 MagForce Nanotechnologies AG 51 Randomized Controlled 51 Cellular Therapy ISCT 51 Kahalalide F 51 CALGB # [002] 51 Immunodeficiency 51 Neuroprotection 51 syngeneic 51 Kommunalkredit Austria AG 51 prospectively evaluated 51 Acute Stroke 51 Digital Mammographic Imaging 51 Süss MicroTec AG 51 controlled dose escalation 51 Hsp# Inhibitor 51 National Surgical Adjuvant 51 Ultrasound Guided 51 Randomized Clinical Trial 51 Ultrasound Imaging 51 Randomized Phase 51 Immunogenetics 51 Agendia BV 51 Hypertension ESH 50 Myocardial Infarction 50 Prospective Randomized Trial 50 Relapsed Refractory 50 undergone radical prostatectomy 50 retrospective cohort study 50 Ovarian PLCO Cancer 50 Azacitidine 50 pT2 50 INSPIRE Trial Phase III 50 Severe Sepsis 50 Malignant Lymphoma 50 Hyperlipidemia 50 Cardiology ESC Congress 50 Immune Mediated 50 Non Alcoholic Steatohepatitis 50 UEGW 50 Nilotinib 50 NKI AVL 50 retrospectively analyzed 50 Pancreas Transplant 50 Cytology 50 Artificial Liver 50 Screening Trial DMIST 50 TO AVOID PREGNANCY WHILE 50 RE LY ® 50 Bipolar Disorders 50 Acute Myocardial Infarction 50 Marrow Transplantation EBMT 50 rapist Josef Fritzl 50 biliary tract cancer 50 Immunodeficiencies 50 stage IIIb IV 50 ST Segment Elevation 50 chemotherapy cisplatin 50 Eculizumab 50 #p# [003] 50 unfractionated heparin UFH 50 retrospective observational study 50 Gynecological Oncology 50 Court Acquits 50 colorectal carcinoma 50 Hospital Clínic 50 REACH Registry 50 Carotid Stenting 50 TELEPERFORMANCE 50 Phase IIIb study 50 Coronary Revascularization 50 Ovarian Tissue 50 Systemic Sclerosis 50 Tumor Response 50 CHAMPION PCI 50 Endocrine Society #st 50 Prostate Cancer Diagnosis 50 multicenter Phase II 50 ARRY # 50 Volker Mueller 50 Lung Cancer Trial 49 rightist Haider 49 Bendamustine 49 Organ Transplantation 49 Trandolapril 49 Cooperative Oncology 49 Acute Ischemic Stroke 49 BR.# 49 Phase 2b Clinical Trial 49 PregLem SA 49 oral deforolimus 49 Urological Association 49 placebo controlled Phase III 49 Active Biotech AB 49 metastatic colorectal 49 Cancer Incidence Mortality 49 Bone Marrow Transplantation 49 Microalbuminuria 49 Acute Decompensated Heart Failure 49 stage IIIB 49 Myocardial Infarction Study 49 HCV Protease Inhibitor 49 NO# [002] 49 Sipuleucel T 49 Fresenius Biotech 49 ExTRACT TIMI 49 kidney urologic 49 Acute Coronary Syndromes 49 Severe Asthma 49 GAAP FER 49 essential thrombocythemia ET 49 Image Guided Surgery 49 TMC# C# 49 HCV SPRINT 49 REALITY Trial 49 liver transplant recipients 49 IMiDs ® compound 49 multicenter multinational 49 Bowel Project 49 aplastic anemia AA 49 symptomatic BPH 49 Placebo Controlled Trial 49 Minimally Invasive Therapy 49 SORT OUT III 49 counterpart Ursula Plassnik 49 multicentre randomized double 49 Phase Ib Clinical Trial 49 Embolic Protection 49 Degarelix 49 XPEL Announces 49 Clinical Antipsychotic Trials 49 Inflammatory Bowel Diseases 49 Parenteral Nutrition 49 ENESTnd 49 skier Didier Cuche 49 Hematologic 49 Marrow Transplantation 49 familial amyloidotic polyneuropathy FAP 49 Phase 1b clinical trials 49 GELA 49 Sanochemia Pharmazeutika AG 49 EchoCRT 49 alfa 2a 49 Watchful Waiting 49 myelodysplastic myeloproliferative diseases 49 Delcath Phase III 49 HDAC Inhibitor 49 ug dose 48 Hip Arthroplasty 48 Novel Inhibitor 48 Hormone Refractory Prostate Cancer 48 RUAG Aerospace 48 Carotid Revascularization Endarterectomy vs. 48 SOBI 48 MOLOGEN AG 48 SANTE 48 Patient Registry 48 NICE SUGAR 48 nonmetastatic 48 CLL8 48 intratumoral injection 48 ICON7 48 AVOREN 48 LUX Lung 48 Follicular Lymphoma 48 evaluating tivozanib 48 Paediatric Infectious Diseases 48 seropositivity 48 Enzastaurin 48 BRIM3 48 Immunohistochemistry 48 journal Psychopathology 48 blind randomized controlled 48 multicenter study 48 Estrogen Receptor 48 JenaValve 48 urothelial carcinoma 48 chancellor Wolfgang Schussel 48 Francophone du 48 Randomized Evaluation 48 Insulin Resistance 48 multicentre study 48 Mirsad Bektasevic 48 prospective nonrandomized 48 mg kg Hematide 48 BRAF V#E 48 RhuDex ™ 48 SABCS 48 Antithrombin 48 Carotid Endarterectomy 48 Super Combi 48 Solid Tumors 48 Multiple Ascending Dose 48 Subgroup analysis 48 metastatic malignant 48 Xelox 48 Initiated Phase 48 Treatment Outcome 48 completely resected 48 Group RTOG 48 Alitretinoin 48 genotype 1b 48 Peginterferon 48 relapsed MM 48 BRIM2 48 resected pancreatic cancer 48 multicentre 48 Preimplantation Genetic Diagnosis 48 Stage IIIb 48 Paroxysmal Nocturnal Hemoglobinuria 48 HepaSphere 48 Related Mortality 48 financial daily Wirtschaftsblatt 48 Heterozygous Familial Hypercholesterolemia 48 Trial PCPT 48 ABCB1 48 papillary thyroid carcinoma 48 composer Franz Schubert 48 metastatic gastric 48 Stenting Trial CREST 48 Demonstrates Sustained 48 underwent CABG 48 Tanespimycin 48 CHARISMA trial 48 Pathogen Detection 48 multicenter randomized placebo controlled 48 prostate cancer CRPC 48 Cloretazine ® 48 dopamine D2 47 der Omikron Data 47 cathepsin K inhibitor 47 Tocilizumab 47 PRESEPT 47 Enzyme Replacement Therapy 47 registrational Phase 47 Female Urology 47 Echocardiographic 47 Biological Therapy 47 Stent Placement 47 Sorafenib HCC Assessment 47 Stereotactic Body Radiation Therapy 47 Meta analyzes 47 WorldHeart Announces 47 galiximab 47 T1c 47 prospective cohort 47 TRO# 47 HuMax EGFr 47 International Myeloma Workshop 47 IIa clinical 47 Dywidag 47 chancellor Wolfgang Schüssel 47 ATOSS Software AG 47 Hepatocellular Carcinoma HCC 47 observational cohort study 47 Urology EAU 47 Cardiotoxicity 47 ImmunoCAP ® 47 Gynecological Cancer 47 EURIDIS 47 randomized multicentre 47 Clavis Pharma ASA 47 RECORD1 47 allogeneic hematopoietic stem cell 47 Neuroradiology 47 Mantle Cell Lymphoma 47 RE MODEL 47 Myeloproliferative Neoplasms 47 epoetin alpha 47 underwent resection 47 Biovitrum AB 47 nilotinib Tasigna 47 randomized multicenter 47 evaluating mipomersen 47 Cutaneous T 47 PKC# 47 prospective multicenter 47 DEB# 47 Ortivus AB 47 Sidec 47 Noscira 47 phase IIIb 47 ritonavir boosted 47 Aortic Valve Replacement 47 HCV infected 47 glucocorticoid induced osteoporosis 47 Unstable Angina 47 STOCKHOLM Herta Mueller 47 Liver Transplants 47 retrospective cohort 47 Afatinib 47 HGPIN 47 HER2 expression 47 Dermatological 47 HBeAg positive chronic hepatitis 47 Naive Patients 47 fallopian tube carcinoma 47 Castration Resistant Prostate Cancer 47 multicenter randomized 47 Translational Oncology 47 trastuzumab emtansine T DM1 47 PROSTVAC ® 47 Helg Sgarbi 47 fosbretabulin 47 Thrombolysis 47 chancellor Wolfgang Schuessel 47 Renal Cell Carcinoma RCC 47 Certican 47 Embryology ESHRE 47 R darbepoetin alfa 47 J. Clin 47 humanized interleukin 6 47 Arteriosclerosis 47 Folfox 47 Affimed Therapeutics AG 47 Vilant 47 Granted Orphan Drug 47 prospective randomized multicenter 47 Artificial Cornea 47 metastatic GIST 47 adjuvant radiotherapy 47 Total Knee Arthroplasty 47 Contrast Enhanced 47 Protherics PLC announces 47 Mammalian Cell Culture 47 Study Shows Benefits 47 RIO Lipids 47 pancreatic adenocarcinoma 47 Small Diameter 47 Novel Therapeutic 47 AFFiRiS 47 treatment naïve genotype 47 ERSPC 47 pertuzumab 47 MindUp BioResearch 47 ESHO 47 motesanib diphosphate 47 GROUPE STERIA 47 sorafenib Nexavar 47 Intravascular 47 Tissue Repair 47 Safinamide 47 prospectively randomized 47 Protease Inhibitors 47 Hepatic 47 IL# PE#QQR 47 Late Breaker 47 Insulin Therapy 47 recurrent metastatic 47 Telatinib 47 CAMMS# 47 Reinhard Haller 47 STRIDE PD 47 assessing T DM1 47 Kleinszig 47 ecotel communication ag 47 Gynecologic Cancer Society 46 Daptomycin 46 cisplatin gemcitabine 46 PEG IFN 46 Genetic Epidemiology 46 Renal Tumors 46 Alkaline Phosphatase 46 Laryngeal Cancer 46 Lp PLA 2 46 Atlas Copco Acquires 46 Mycophenolate Mofetil 46 insulin glulisine 46 landmark ATHENA 46 Virologic 46 NSABP 46 lymphoid malignancies 46 ENDEAVOR IV 46 Group NCIC CTG 46 Polymorphism 46 SUTENT ® 46 JAK2 Inhibitor 46 hereditary medullary thyroid 46 striker Roland Linz 46 Tesmilifene 46 pegylated liposomal doxorubicin 46 Bayer HealthCare Onyx Pharmaceuticals 46 candesartan cilexetil 46 life sentence upheldA 46 doxorubicin cyclophosphamide 46 Leon Keder spokesman 46 Decompensated 46 Drug Eluting Coronary Stent 46 Renal Transplant 46 metastatic pancreatic 46 Warsaw Monika Lewandowska 46 NeoRecormon 46 Biomolecular Screening 46 Diamyd Medical Diamyd 46 IDTM 46 HPV Vaccine Gardasil 46 mg BID dose 46 multicenter randomized clinical 46 Doping Tests 46 PRECiSE 46 atypical Hemolytic Uremic Syndrome 46 AHCC 46 unstable angina pectoris 46 HPV-#/# 46 decompensated liver disease 46 underwent surgical resection 46 randomized Phase IIb 46 Infielder Esteban 46 MIVI TRUST 46 refractory chronic lymphocytic 46 Cellular Immunotherapy 46 somatostatin analog 46 Certolizumab pegol 46 vinca alkaloid 46 Randomised Study 46 aminotransferase 46 Phase 2b Trial 46 tumor necrosis 46 LymphoStat B belimumab 46 Percutaneous Tibial Nerve Stimulation 46 KeyNeurotek 46 Verband der 46 gastric adenocarcinoma 46 PON1 activity 46 XELOX 46 BOLDER II 46 Liver Fibrosis 46 rALLy clinical trial 46 evaluating carfilzomib 46 phase IIa 46 Epratuzumab 46 ECCMID 46 Antisoma AS# 46 ACRIN 46 Andritz AG 46 PICSO ® 46 Phase 2a Clinical Trial 46 Barnabas Sz 46 Surgeons Oncology 46 AA Amyloidosis 46 Cloretazine 46 pediatric acute lymphoblastic 46 erlotinib Tarceva ® 46 serum selenium 46 randomized blinded placebo 46 treatment naive genotype 46 Ozarelix 46 oral ridaforolimus 46 LECTRA 46 Maricica 46 CLARITY study 46 Pregnancy Outcomes 46 Betaferon R 46 Minaret Ban 46 sunitinib Sutent ® 46 icatibant 46 PubliGroupe 46 Left Ventricular 46 antibody MAb 46 bendamustine 46 BARI 2D 46 Islet Transplant 46 recurrent glioblastoma multiforme 46 substudy 46 radical retropubic prostatectomy 46 Solid Tumours 46 Sentinel Lymph Node 46 newspaper Suddeutsche Zeitung 46 adecatumumab 46 teenager Grigor Dimitrov 46 Artificial Organs 46 SWOG 46 prospective randomized controlled 46 Intrinsic Imaging 46 Ocular Pharmacology 46 Renal Function 46 HIV HCV coinfected 46 Nexavar sorafenib 46 Adverse Event 46 CIMZIA TM certolizumab pegol 46 leukemia CLL 46 HBeAg negative chronic hepatitis 46 ENTB 46 Biozentrum 46 docetaxel Taxotere R 46 Hematologic Malignancies 45 Helga Kruger 45 Denufosol 45 Cell Non Hodgkin 45 Splendid Medien AG 45 Bally Technologies GTECH Atronic 45 Autoimmunity 45 Clinical Proteomics 45 K ras mutations 45 HBeAg negative 45 EntreMed Presents 45 Projected Release Date 45 randomized multicenter trial 45 Flu Cy 45 SinuNase ™ 45 Ambassador Eckart Cuntz 45 dose escalation Phase 45 RTOG 45 Hodgkin lymphoma HL 45 Phase Ib clinical 45 Arno Therapeutics 45 EFNS 45 relapsing remitting MS RRMS 45 Diabetic Kidney Disease 45 Mahmood El Farnawani 45 goserelin 45 ECASS 45 ABRF 45 Taxotere ® 45 docetaxel Taxotere ® 45 clinico pathological 45 Copegus ribavirin 45 BUCHAREST Thomson Financial 45 lymphocytosis 45 REVIVE Diabetes 45 HER2 positive metastatic breast 45 blind multicenter 45 acadesine 45 biochemical relapse 45 COPERNICUS 45 Helicobacter pylori eradication 45 neoadjuvant treatment 45 Adtegrity.com Reports 45 ZACTIMA 45 NABTT 45 cancer mCRC 45 CC genotype 45 HCV RESPOND 2 45 ORIDIS Biomed 45 gemcitabine carboplatin 45 blinded randomized placebo controlled 45 Hematopoietic 45 Montalescot 45 MAGE A3 ASCI 45 Cardiac Troponin 45 plus prednisone 45 Randomised 45 neoadjuvant 45 Coronary Intervention 45 Irinotecan 45 Blinatumomab 45 Allograft 45 RoACTEMRA 45 GOUT 45 subanalysis 45 acute humoral rejection 45 antiphospholipid syndrome APS 45 Aryplase 45 Molecular Detection 45 nonsmall cell lung cancer 45 Cancer Incidence 45 metastatic neuroendocrine tumors 45 MAGE A3 45 Clinical Virology 45 Prospective Randomized Study 45 businessman Arpad Busson 45 Group B CALGB 45 LUMINATE 45 RE LY trial 45 IL#B 45 Molecular Pathology 45 Postoperative Pain 45 MORAb 45 HBeAg positive 45 gene polymorphism 45 Risk Stratification 45 TAXUS ATLAS 45 Erythropoiesis Stimulating Agents ESAs 45 Unternehmens Invest AG 45 LAB CGRP 45 Myelodysplastic Syndromes MDS 45 patientswith 45 efavirenz EFV 45 Advanced Heart Failure 45 metastatic HRPC 45 Tripep 45 Tumor Microenvironment 45 champions Graz AK 45 Nylon Nickel 45 satraplatin Phase 45 monoclonal anti 45 CIMZIA TM 45 Vienna Austria AHN 45 controlled multicenter 45 Myelodysplastic Syndrome MDS 45 HYVET 45 INCB# [003] 45 Osteoporotic Fractures 45 Phase III randomized 45 suspect Babenko 45 Investigational Drug 45 abacavir Ziagen 45 agalsidase alfa 45 PhotoCure 45 Central Venous Catheters 45 Biodesix 45 CyberKnife Radiosurgery 45 Breast Cancer Intergroup 45 Paediatric Endocrinology 45 Targeted Anticancer Therapies 45 Flamel Technologies Announces 45 double blinded randomized 45 Hypertriglyceridemia 45 Procyon Biopharma 45 Breast Surgeons ASBS 45 Vicor Technologies Announces 45 lymphoproliferative disorders 45 shooter Katerina Emmons 45 PET Scanner 45 Pediatric Oncology Branch 45 Phase IIIb clinical 45 LHON 45 Sequenced Treatment Alternatives 45 Thyroid Hormone 45 BZA CE 45 prime minister Paavo Lipponen 45 Prostate Cancer Prevention 45 fluvastatin 45 ACTEMRA TM 45 NorDiag ASA 45 prospective multicenter study 45 EBMT 45 Clusterin 45 filmmaker Cristian Mungiu 45 midfielder Pal Dardai 45 locoregional recurrence 45 demonstrated antitumor activity 45 Bjorn Hurtig Assange 45 Society CTOS 45 dimeglumine 45 Bucindolol 45 DYMTF 45 HLA A2 45 thetreatment 45 Vascugel 45 MMX mesalamine 45 Cytogenetic 45 Resource Exchange AGRE 45 STEP BD 45 FOLFIRI chemotherapy 45 IIIb 45 AIR2 Trial 45 ACUITY trial 45 hepatocellular carcinoma HCC 45 antiretroviral naïve 45 darunavir r 45 AVAiL 45 receptor tyrosine kinase inhibitor 45 Resten MP 45 Retina Specialists 45 FluCAM arm 45 neratinib 45 tramiprosate Alzhemed TM 45 Elbit Imaging Announces 45 ASCO GU 44 Bishop Klaus Kueng 44 Pulmonary Vein Isolation 44 unresectable stage 44 CYPHER Stent 44 Daewoo Mangalia Heavy Industries 44 Histocompatibility 44 AGOR AG 44 Pirfenidone 44 lymph node metastasis 44 Cytopathology 44 Match Fixtures 44 F FDG PET 44 histological subtype 44 CTAP# Capsules 44 cytologically confirmed 44 Katalin Marosi 44 counterpart Stjepan Mesic 44 standard chemotherapy regimen 44 multicenter 44 Velcade bortezomib 44 Biotec Pharmacon 44 polyarticular 44 Yondelis ® 44 Ocrelizumab 44 Telmisartan 44 Circulatory Support 44 prucalopride 44 thalidomide Thalomid 44 RhuDex R 44 stage IIIb 44 sunitinib Sutent 44 EGFR HER2 44 ERalpha 44 mycophenolate mofetil MMF 44 Hematopathology 44 Colorectal Cancer Screening 44 histologically confirmed 44 neovascular age 44 Analytik 44 recurrent glioma 44 Recurrent Prostate Cancer 44 Adult Stem Cell Therapy 44 interferon gamma 1b 44 advanced hepatocellular carcinoma 44 heFH 44 advanced metastatic renal 44 prostate cancer CaP 44 Initiates Phase 2b 44 counterpart Stipe Mesic 44 Control NIBSC 44 SCOR Holding 44 MDACC 44 VERBIO 44 Cloretazine R 44 malignant pleural mesothelioma 44 SCCHN 44 scientific journal PNAS 44 CD# monoclonal antibody 44 SNCA 44 Steno Diabetes Center 44 BARACLUDE ® 44 Armin Trojer 44 axillary lymph nodes 44 Encision Reports 44 Peg IFN 44 Gene Expression Analysis 44 Alfons Haider 44 epoetin beta 44 Trophos 44 zu entwickeln 44 Study ADCS 44 cagA 44 ELACYT 44 Urologic 44 Autoimmune Diseases 44 evaluating Actimmune 44 Molecular Biology Organization EMBO 44 Clinical Oncology Annual Meeting 44 PegIFN 44 HNSCC 44 histamine dihydrochloride 44 Profitable Third Quarter 44 HBeAg 44 R vitespen 44 Pharmacologic 44 ATACAND 44 Phase 1a clinical 44 Islet Transplantation 44 mRCC 44 nasopharyngeal carcinoma 44 advanced adenomas 44 Multiethnic Study 44 Pancreatic 44 LEXIVA r 44 Lenalidomide 44 thrombocytopenic 44 adjuvant trastuzumab 44 Ziprasidone 44 Preclinical Efficacy 44 Hyperthermic Oncology ESHO 44 Edge STudy 44 pan HDAC inhibitor 44 RECIST Response Evaluation Criteria 44 randomized controlled Phase 44 #:# -# [003] 44 trabectedin 44 EOquin TM phase 44 Systemic Lupus Erythematosus SLE 44 CCX# B 44 T2DM 44 nucleoside naive 44 Flavio Carboni 44 multiple myeloma MM 44 laparoscopic radical nephrectomy 44 CRLX# 44 Thal Dex 44 Admits Doping 44 spokesman Alexander Marakovits 44 prospective randomized placebo 44 colorectal cancer CRC 44 Grouped Hockey 44 Centro Monzino 44 syngo ® 44 mGluR5 negative 44 MAXIMA 44 Radiation Oncologists 44 ESHRE 44 Orqis Medical 44 Quinamed 44 metastatic RCC 44 Amstetten Lower 44 Largest Database 44 q#h 44 ofatumumab HuMax CD# 44 YONDELIS 44 registrational trial 44 HCV genotype 44 Clinical Genetics 44 Pemetrexed 44 Sylwester Szmyd 44 BCR ABL1 44 B streptococcal 44 VIR# 44 MEND CABG 44 Zweidler McKay 44 Basel Switzerland ots PRNewswire 44 ARIXTRA 44 Phase IIIb 44 dose dose escalation 44 VISP 44 Dasatinib 44 TASQ 44 microplasmin Phase III 44 iniparib BSI 44 Connective Tissue Oncology 44 Motesanib 44 TRANSFORMS 44 Ele Ferrannini 44 placebo controlled Phase 44 Measurement Devices 44 breast carcinomas 44 MGd 43 randomized multicenter Phase III 43 Oncology ASTRO 43 controlled multicenter Phase 43 Podium Presentation 43 Microfluidic Device 43 Statutory Accounts 43 phase IIb study 43 ToGA 43 genotype 1a 43 PARTNER Trial 43 ACR# ACR# 43 ECCO ESMO 43 plus COPEGUS 43 locoregional 43 multicenter clinical 43 refractory cutaneous T 43 sodium glucose cotransporter 43 serum leptin 43 mertansine 43 Dr. Carlo Urbani 43 YONDELIS R 43 ARRIS Announces 43 CanAg 43 ankylosing spondylitis AS 43 mCRC patients 43 Pamidronate 43 mutated K ras 43 rider Bernhard Kohl 43 Cell Transplant 43 multicentre phase 43 Therapeutic Intervention 43 dose melphalan 43 Neurodegenerative Disorders 43 paclitaxel poliglumex 43 Aplidin 43 TMPRSS2 ERG 43 colon carcinoma 43 FOLFOX4 43 Multicenter Automatic Defibrillator Implantation 43 Uterine Fibroid 43 Hematology Meeting 43 Phase #b/#a clinical 43 AVADO 43 epithelial tumors 43 Aflibercept 43 REpower Systems 43 coinfected patients 43 pegylated interferon alfa 2b 43 Andre Bamberski 43 histologic subtype 43 Febuxostat 43 Onrigin TM 43 basal cell carcinoma BCC 43 Cimzia ® certolizumab pegol